Evidence map›Paper›PMID 23999498›Full record

ArticleThe Journal of experimental medicine2013

Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss.

Mario Kreutzfeldt, Andreas Bergthaler, Marylise Fernandez, Wolfgang Brück, Karin Steinbach, Mariann Vorm, Roland Coras, Ingmar Blümcke, Weldy V Bonilla, Anne Fleige and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD4Journal of neuroinflammation · 2022
    Article
  19. Impact of T cells on neurodegeneration in anti-GAD65 limbic encephalitis.Annals of clinical and translational neurology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Mario KreutzfeldtDepartment of Pathology and Immunology and 2 World Health Organization Collaborating Centre for Vaccine Immunology, University of Geneva, 1211 Geneva, Switzerland.
Andreas Bergthaler
Marylise Fernandez
Wolfgang Brück
Karin Steinbach
Mariann Vorm
Roland Coras
Ingmar Blümcke
Weldy V Bonilla
Anne Fleige
Ruth Forman
Werner Müller
Burkhard Becher
Thomas Misgeld
Martin Kerschensteiner
Daniel D Pinschewer
Doron Merkler
University of Geneva · CHUniversity of Göttingen · DEMunich Cluster for Systems Neurology · DEUniversitätsklinikum Erlangen · DEUniversity of Manchester · GBWorld Health Organization · CHHelmholtz Centre for Infection Research · DEUniversity of Zurich · CH

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Neurons are postmitotic and thus irreplaceable cells of the central nervous system (CNS). Accordingly, CNS inflammation with resulting neuronal damage can have devastating consequences. We investigated molecular mediators and structural consequences of CD8(+) T lymphocyte (CTL) attack on neurons in vivo. In a viral encephalitis model in mice, disease depended on CTL-derived interferon-γ (IFN-γ) and neuronal IFN-γ signaling. Downstream STAT1 phosphorylation and nuclear translocation in neurons were associated with dendrite and synapse loss (deafferentation). Analogous molecular and structural alterations were also found in human Rasmussen encephalitis, a CTL-mediated human autoimmune disorder of the CNS. Importantly, therapeutic intervention by IFN-γ blocking antibody prevented neuronal deafferentation and clinical disease without reducing CTL responses or CNS infiltration. These findings identify neuronal IFN-γ signaling as a novel target for neuroprotective interventions in CTL-mediated CNS disease.

Indexed as

AdolescentAdultAnimalsCD8-Positive T-LymphocytesCell NucleusChildDendritesfas ReceptorHumansInterferon-gammaInterferon gamma ReceptorLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, TransgenicNeuronsfas ReceptorInterferon-gammaInterferon gamma ReceptorPerforinReceptors, InterferonSTAT1 Transcription Factor

Identifiers

PMID23999498
PMCPMC3782053
OpenAlexW2101172791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.